AZYO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 Sep 2023 @ 15:59):

Stats
Today's Volume	8 103.00
Average Volume	432 734
Market Cap	24.21M
EPS	$0 ( 2024-03-20 )
Next earnings date	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.683
ATR14	$0.182 (13.09%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-28	Highcape Capital, Llc	Sell	1 436 077	Class A Common Stock
2023-12-28	Highcape Capital, Llc	Sell	2 154 116	Warrants (right to buy)
2023-12-28	Highcape Capital, L.p.	Sell	1 436 077	Class A Common Stock
2023-12-28	Highcape Capital, L.p.	Sell	2 154 116	Warrants (right to buy)
2021-09-21	Highcape Capital, Llc	Buy	2 837 128	Class A Common Stock

INSIDER POWER
-80.03
Last 95 transactions
Buy: 17 583 923 \| Sell: 9 483 030

Volume Correlation

Long: -0.09 (neutral)

Short: -0.50 (neutral)

Signal:(48.31) Neutral

Aziyo Biologics, Inc. Correlation

10 Most Positive Correlations
CWBC	0.953
WTFCP	0.946
PWOD	0.945
UCBIO	0.944
ATLO	0.943
NWFL	0.939
WSBCP	0.939
RMRM	0.938
BIRD	0.936
PTRS	0.933

10 Most Negative Correlations
BOCH	-0.968
DRNA	-0.962
MMAC	-0.951
SUMO	-0.922
SOPH	-0.919
NETE	-0.914
ALBO	-0.913
SMED	-0.911
CMPI	-0.906
SHSP	-0.897

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aziyo Biologics, Inc. Correlation - Currency/Commodity

0.75
( moderate )

0.71
( moderate )

0.00
( neutral )

-0.19
( neutral )

-0.56
( weak negative )

-0.88
( strong negative )

Aziyo Biologics, Inc. Financials

Annual	2022
Revenue:	$49.19M
Gross Profit:	$19.22M (39.08 %)
EPS:	$-2.38

Q3	2023
Revenue:	$6.13M
Gross Profit:	$2.84M (46.37 %)
EPS:	$-0.570

Q2	2023
Revenue:	$10.30M
Gross Profit:	$980 000 (9.52 %)
EPS:	$-0.650

Q1	2023
Revenue:	$13.05M
Gross Profit:	$6.33M (48.51 %)
EPS:	$-0.490

Financial Reports:

No articles found.

Aziyo Biologics, Inc.

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.